J. Goldman & CO LP Puma Biotechnology, Inc. Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $2.24 Million - $3.25 Million	-238,617 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $1.86 Million - $2.89 Million	238,617 New	238,617 $2.45 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $1.9 Million - $3.16 Million	-31,829 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $1.45 Million - $2.04 Million	15,429 Added 94.08%	31,829 $3.15 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $1.18 Million - $1.96 Million	16,400	16,400 $1.96 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.